Chagas heart disease (CHD) affects approximately 30% of patients chronically infected with
the protozoa Trypanosoma cruzi. CHD is classified into four stages of increasing severity …

Chagas disease persists as a global public health problem due to the high morbidity and
mortality burden. Despite the possibility of a cure and advances in transmission control …

Post-infectious conditions present major health burdens but remain poorly understood. In
Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that …

SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Abstract Purpose of Review This review seeks to describe the updates in the literature–
particularly with regards to the epidemiology and diagnosis of Chagas disease. Additionally …

The usage of nanotechnology in the fight against parasitic diseases is in the early stages of
development, but it brings hopes that this new field will provide a solution to target the early …

Aims This study aimed to estimate the annual mortality risk and its determinants in chronic
Chagas cardiomyopathy. Methods and results We conducted a systematic search in …

A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …

Chagas disease (CD) is caused by the flagellate protozoan Trypanosoma cruzi. It is
endemic in Latin America. Nowadays around 6 million people are affected worldwide, and …

Chronic Chagasic cardiomyopathy develops years after infection in 20–40% of patients, but
disease progression is poorly understood. Here, we assessed Trypanosoma cruzi parasite …